The sustained and growing body of research on this compound, spanning multiple countries, research institutions, and animal models, reflects a level of reproducibility that supports continued serious investigation
CAS 1401708-83-5) is an orally active, blood-brain-barrier-permeable synthetic hexapeptide derived from the endogenous hexapeptide angiotensin IV (Ang IV)
Molecular Class: Synthetic small-molecule research compound Net Content: 5 mg Purity: 99% (research-grade) Physical State: Lyophilized powder Intended Use: Laboratory research only Research Applications In published scientific and supplier literature, 5 Amino-1MQ is described as a synthetic small-molecule research compound examined within nicotinamide N-methyltransferase (NNMT)associated metabolic and methylation research frameworks under non-clinical laboratory conditions
(2001) Proceedings of the National Academy of Sciences (PNAS) , 98(22): 1243812443 Foundational study demonstrating that peptides from the amino-terminal MDM-2 binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells, establishing the basis for PNC-27s design
Never shake vigorously Peptide typically dissolves within 10 to 20 minutes to form clear solution Inspect for cloudiness, discoloration, or particles indicating degradation requiring disposal For a 5 mg Bpc-157 vial with 2.5 mL bacteriostatic water, the resulting 2 mg per mL concentration means 0.125 mL (12.5 units on insulin syringe) delivers 0.25 mg
Cancer 96 , 19141923 (2007)
